Literature DB >> 4564886

Complement-fixing antigens in lymphoid cell lines of American origin.

K J McCormick, D M Mumford, W A Stenback, J J Trentin.   

Abstract

Lymphoid cell lines from Americans with infectious mononucleosis (Choate, EH IV, and OP), and from a normal American (Cassio), were tested for presence of herpes-like virus by electron microscopy (EM) and immunofluorescence (IF), and for complement-fixing (CF) antigens, using both American and African sera. Whereas earlier tests of seven African (Burkitt) lymphoma cell lines showed an absolute correlation between presence of herpes-like virus and CF reactivity with either African or American sera, the same was not true of the American cell lines. Herpes-like particles were found in the Cassio line by both EM and IF, and in a few cells of the OP line by IF, but not by EM. The virus was not found in the Choate or EH IV lines by either EM or IF. African sera from either normal individuals or patients with Burkitt lymphoma contained CF antibodies to extracts of Cassio and OP cells. Normal American sera contained CF antibodies to these extracts as well as to extracts of Choate cells. The EH IV cell line did not produce CF antigens detectable with either African or American sera. The data indicate that the CF antigens of the herpes virus-negative Choate cell line were serologically distinct from those in Burkitt lines. However, it is possible that the antigens from both sources are related to the presence of the genome of the herpes-like virus.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564886      PMCID: PMC422519          DOI: 10.1128/iai.6.3.218-225.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.

Authors:  V Vonka; M Benyesh-Melnick; R M McCombs
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

2.  Studies of Burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics.

Authors:  J Minowada; G Klein; P Clifford; E Klein; G E Moore
Journal:  Cancer       Date:  1967-09       Impact factor: 6.860

3.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

4.  Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line.

Authors:  J H Pope; M K Horne; E J Wetters
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

5.  Characteristics of new cell lines derived from Burkitt lymphomas.

Authors:  J S Nadkarni; J J Nadkarni; P Clifford; G Manolov; E M Fenyö; E Klein
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

6.  Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures.

Authors:  P Gerber; D R Deal
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

7.  Infectious mononucleosis: detection of herpeslike virus and reticular aggregates of small cytoplasmic particles in continuous lymphoid cell lines derived from peripheral blood.

Authors:  H L Moses; P R Glade; J A Kasel; A S Rosenthal; Y Hirshaut; L N Chessin
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

8.  Complement-fixation test for detection of herpes-like viruses in cell cultures of Burkitt's lymphoma.

Authors:  K J McCormick; W A Stenback; J J Trentin; G Klein; J S Nadkarni; J J Nadkarni; P Clifford
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

9.  Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias.

Authors:  D Armstrong; G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

10.  Attempts to find human adenovirus type-12 tumor antigens in human tumors.

Authors:  K J McCormick; G L Van Hoosier
Journal:  J Natl Cancer Inst       Date:  1968-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.